Logo image of DRW8.DE

DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock

61.2 EUR
-0.6 (-0.97%)
Last: 1/13/2026, 9:21:28 AM
Fundamental Rating

5

DRW8 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. DRW8 has an average financial health and profitability rating. DRW8 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. DRW8 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DRW8 had positive earnings in the past year.
In the past year DRW8 had a positive cash flow from operations.
Of the past 5 years DRW8 4 years were profitable.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
DRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

DRW8 has a Return On Assets of 3.99%. This is comparable to the rest of the industry: DRW8 outperforms 57.35% of its industry peers.
With a Return On Equity value of 8.02%, DRW8 perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
DRW8 has a better Return On Invested Capital (7.67%) than 63.24% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROIC 7.67%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW8.DE Yearly ROA, ROE, ROICDRW8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

DRW8 has a Profit Margin of 3.54%. This is comparable to the rest of the industry: DRW8 outperforms 44.12% of its industry peers.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
DRW8 has a Operating Margin of 6.02%. This is in the lower half of the industry: DRW8 underperforms 61.76% of its industry peers.
DRW8's Operating Margin has improved in the last couple of years.
DRW8 has a worse Gross Margin (45.35%) than 67.65% of its industry peers.
DRW8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW8.DE Yearly Profit, Operating, Gross MarginsDRW8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DRW8 has less shares outstanding
DRW8 has more shares outstanding than it did 5 years ago.
DRW8 has a better debt/assets ratio than last year.
DRW8.DE Yearly Shares OutstandingDRW8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW8.DE Yearly Total Debt VS Total AssetsDRW8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DRW8 has an Altman-Z score of 2.67. This is not the best score and indicates that DRW8 is in the grey zone with still only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score (2.67) which is in line with its industry peers.
DRW8 has a debt to FCF ratio of 2.16. This is a good value and a sign of high solvency as DRW8 would need 2.16 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.16, DRW8 is doing good in the industry, outperforming 76.47% of the companies in the same industry.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
DRW8 has a Debt to Equity ratio of 0.10. This is in the better half of the industry: DRW8 outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Altman-Z 2.67
ROIC/WACC1.2
WACC6.38%
DRW8.DE Yearly LT Debt VS Equity VS FCFDRW8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

DRW8 has a Current Ratio of 1.76. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8 has a Current ratio (1.76) which is in line with its industry peers.
DRW8 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DRW8 (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.03
DRW8.DE Yearly Current Assets VS Current LiabilitesDRW8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

DRW8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.68%.
Measured over the past years, DRW8 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%

3.2 Future

The Earnings Per Share is expected to grow by 7.93% on average over the next years.
Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 2.85% on average per year.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y2.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRW8.DE Yearly Revenue VS EstimatesDRW8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DRW8.DE Yearly EPS VS EstimatesDRW8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.49, the valuation of DRW8 can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.53% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.25, DRW8 is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.34, the valuation of DRW8 can be described as reasonable.
Based on the Price/Forward Earnings ratio, DRW8 is valued cheaply inside the industry as 92.65% of the companies are valued more expensively.
DRW8's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.98.
Industry RankSector Rank
PE 9.49
Fwd PE 8.34
DRW8.DE Price Earnings VS Forward Price EarningsDRW8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.53% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DRW8 is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.39
EV/EBITDA 3.38
DRW8.DE Per share dataDRW8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

DRW8's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.76
PEG (5Y)0.26
EPS Next 2Y11.08%
EPS Next 3Y11.69%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.28%, DRW8 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.13, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 92.65% of the companies listed in the same industry.
DRW8's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 3.28%

5.2 History

The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
DRW8.DE Yearly Dividends per shareDRW8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
DRW8.DE Yearly Income VS Free CF VS DividendDRW8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW8.DE Dividend Payout.DRW8.DE Dividend Payout, showing the Payout Ratio.DRW8.DE Dividend Payout.PayoutRetained Earnings

DRAEGERWERK AG

FRA:DRW8 (1/13/2026, 9:21:28 AM)

61.2

-0.6 (-0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29
Earnings (Next)03-24 2026-03-24
Inst Owners10.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.15B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (34.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.28%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 9.49
Fwd PE 8.34
P/S 0.34
P/FCF 8.39
P/OCF 5.66
P/B 0.76
P/tB 0.98
EV/EBITDA 3.38
EPS(TTM)6.45
EY10.54%
EPS(NY)7.34
Fwd EY11.99%
FCF(TTM)7.29
FCFY11.92%
OCF(TTM)10.82
OCFY17.68%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.76
PEG (5Y)0.26
Graham Number108
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROCE 10.2%
ROIC 7.67%
ROICexc 8.64%
ROICexgc 10.67%
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
FCFM 4%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Debt/EBITDA 0.44
Cap/Depr 44.92%
Cap/Sales 1.93%
Interest Coverage 11.48
Cash Conversion 57.51%
Profit Quality 113.22%
Current Ratio 1.76
Quick Ratio 1.03
Altman-Z 2.67
F-Score7
WACC6.38%
ROIC/WACC1.2
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y2.85%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.13%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%

DRAEGERWERK AG / DRW8.DE FAQ

Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?

ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.


What is the valuation status of DRAEGERWERK AG (DRW8.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.


What is the profitability of DRW8 stock?

DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DRW8 stock?

The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 9.49 and the Price/Book (PB) ratio is 0.76.


What is the expected EPS growth for DRAEGERWERK AG (DRW8.DE) stock?

The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.38% in the next year.